The mechanisms underlying Japanese encephalitis virus (JEV) pathogenesis need to be thoroughly explored to delineate therapeutic approaches. It is believed that JEV manipulates the innate and adaptive compartments of the host's immune system to evade immune response and cross the blood-brain barrier. The present study was thus designed to investigate the functional modulation of DCs after exposure to JEV and to assess the consequences on CD4 Eur. J. Immunol. 2014Immunol. . 44: 1363Immunol. -1374 Introduction Japanese encephalitis virus (JEV) is the cause of the most dreaded mosquito-borne disease and epidemic viral encephalitis in the world [1][2][3]. The expanding geographical range and JEV's ability to cause devastating epidemics in nonimmune populations demand an urgent effort toward the development of efficient antiviral therapies [4] or of alternate strategies that can reduce JEV immunopathogenesis. A significant number of studies illustrate the importance of crossing the blood-brain barrier (BBB) for pathogenesis and clinical manifestations of JEV infection [5]. JEV induces the activation of endothelial cells to increase the adhesion and transport the infected leukocytes across the BBB [6]. These findings imply that JEV requires escaping immune surveillance at the periphery, until the essential alterations occur at the BBB. Therefore, modulation of immune cells at the periphery is a prerequisite. In particular, upon modulation of the cells at periphery, JEV generates a favorable microenvironment that facilitates the alteration of BBB integrity [7][8][9][10].The paramount protective function of humoral immunity is well documented in human cases of JEV [11][12][13] as well as in animal models [14][15][16][17]
Results
Replication-competent JEV induces the phenotypic maturation of immature DCsDCs are known to initiate immune responses to invading pathogens. We hypothesized that DCs are privileged targets for modulation by JEV to subvert the immune system and establish successful infection. To evaluate this hypothesis, we first analyzed the effect of JEV on DC activation. The results demonstrate that JEV induces the maturation of DCs at 1 MOI (Fig. 1). The expression of activation markers such as HLA-DR and CD40, and of co-stimulatory molecules such as CD80/B7.1, CD86/B7.2, and CD83, was significantly upregulated on JEV-infected DCs as compared with mock-infected or replication-incompetent JEV-treated DCs ( Fig. 1A-E). We further analyzed the expression of DC-SIGN, which plays a crucial role in DC responses to pathogens [26]. The expression of DC-SIGN was not affected by JEV infection (Fig. 1F), in contrast to observations made with dengue virus, where DC-SIGN expression has been documented to be related to the levels of viral infection [27]. However, a role for DC-SIGN as a possible pattern recognition receptor for JEV cannot be excluded and further investigations are required to explore the role of DC-SIGN in JEV pathogenesis. Interestingly, PD-L1 expression was significantly increased upon infection by re...